Michael Pietrack
Publishes 1 feed
All News
All News
10 posts · contributor
Lately
Roche pours $750M into Oregon manufacturing plant as obesity push expands
All News ·
Scribe’s early-stage IPO standout defies biotech’s derisking trend
All News ·
Regeneron wins FDA approval to challenge Ipsen for rare bone disease market
All News ·
Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision
All News ·
Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future
All News ·
Rewriting the rules of CMV prevention
All News ·
7 biopharma M&A deals where layoffs followed
All News ·
Out of sight, out of work? What’s driving remote job cuts
All News ·
Why pediatric rare oncology outperforms in a volatile biotech market
All News ·
Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: Analysts
All News ·
Everything on this page was read from markup Michael Pietrack published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON
